The antigen 85 complex vaccine against experimental Mycobacterium leprae infection in mice

Area of Science:

• Immunology
• Microbiology
• Vaccinology

Background:

• Leprosy, caused by Mycobacterium leprae, remains a global health concern.
• Bacillus Calmette-Guérin (BCG) is used as a vaccine but offers variable protection against leprosy.
• Identifying specific protective antigens is crucial for developing improved leprosy vaccines.

Purpose of the Study:

• To evaluate the immunoprotective potential of specific proteins from BCG culture filtrate against Mycobacterium leprae infection.
• To determine if the antigen 85 complex (Ag 85) proteins can induce protective immunity against leprosy.

Main Methods:

• Proteins from BCG culture filtrate were isolated and purified.
• Mice were immunized with purified antigen 85 complex (Ag 85) proteins (A, B, and C).
• Immune response, including interferon gamma (IFN-gamma) synthesis, and protection against M. leprae multiplication in mouse foot pads were assessed.

Main Results:

• Immunization with Ag 85 complex proteins conferred significant protection against M. leprae.
• Ag 85A was the most effective antigen, inducing superior protection compared to Ag 85B and Ag 85C.
• A single dose of Ag 85 induced antigen-specific IFN-gamma production and protection exceeding that of live BCG vaccine.

Conclusions:

• The antigen 85 complex, particularly Ag 85A, represents a key immunoprotective molecule against leprosy.
• Ag 85 holds promise as a subunit vaccine component for enhanced leprosy prevention.
• Targeting Ag 85 could lead to more effective strategies for controlling leprosy infection.